Literature DB >> 3177094

Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?

P Vadas1, W Pruzanski, E Stefanski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3177094      PMCID： PMC7096008          DOI： 10.1007/bf02028289

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  36 in total

1.  Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse.

Authors:  P Vadas; W Pruzanski; E Stefanski; B Sternby; R Mustard; J Bohnen; I Fraser; V Farewell; C Bombardier
Journal:  Crit Care Med       Date:  1988-01       Impact factor: 7.598

2.  Isolation and characterization of a phospholipase A2 from an inflammatory exudate.

Authors:  R Franson; R Dobrow; J Weiss; P Elsbach; W B Weglicki
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

Review 3.  Role of secretory phospholipases A2 in the pathobiology of disease.

Authors:  P Vadas; W Pruzanski
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

4.  Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock.

Authors:  P Vadas; J B Hay
Journal:  Can J Physiol Pharmacol       Date:  1983-06       Impact factor: 2.273

5.  Release of vasoactive hormones and circulatory changes in shock.

Authors:  M F Wilson; D J Brackett
Journal:  Circ Shock       Date:  1983

6.  Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.

Authors:  P Vadas
Journal:  J Lab Clin Med       Date:  1984-12

7.  Concordance of endogenous cortisol and phospholipase A2 levels in gram-negative septic shock: a prospective study.

Authors:  P Vadas; W Pruzanski; E Stefanski; J Ruse; V Farewell; J McLaughlin; C Bombardier
Journal:  J Lab Clin Med       Date:  1988-05

8.  Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2.

Authors:  P Vadas; E Stefanski; W Pruzanski
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

9.  Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis.

Authors:  E Stefanski; W Pruzanski; B Sternby; P Vadas
Journal:  J Biochem       Date:  1986-11       Impact factor: 3.387

10.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

Authors:  M Hallman; R Spragg; J H Harrell; K M Moser; L Gluck
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808
View more
  10 in total

1.  Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.

Authors:  W Pruzanski; S Saito; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  The effect of adrenalectomy on interleukin-1 release in vitro and in vivo.

Authors:  M Perretti; C Becherucci; G Scapigliati; L Parente
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Rat liver mitochondrial phospholipase A2 is an endotoxin-stimulated membrane-associated enzyme of Kupffer cells which is released during liver perfusion.

Authors:  G M Hatch; D E Vance; D C Wilton
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

4.  Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.

Authors:  C Kohler; M Carroll; E Tarrant; L Torley; A Wissner
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

5.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

6.  Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.

Authors:  W Pruzanski; D W Wilmore; A Suffredini; G D Martich; A G Hoffman; J L Browning; E Stefanski; B Sternby; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

7.  Compartmental heterogeneity of soluble phospholipases A.

Authors:  P Vadas; W Pruzanski; E Stefanski; B Sternby
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

8.  Induction of circulating group II phospholipase A2 expression in adults with malaria.

Authors:  P Vadas; J Keystone; E Stefanski; K Scott; W Pruzanski
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

9.  Phospholipase A(2) Activity in Gingival Crevicular Fluid from Patients with Periodontal Disease: A possible Marker of Disease Activity.

Authors:  H Ishida; H Shinohara; T Nagata; S Nishikawa; Y Wakano
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

10.  Tenidap sodium inhibits secretory non-pancreatic phospholipase A(2) synthesis by foetal rat calvarial osteoblasts.

Authors:  W Pruzanski; B P Kennedy; H Bosch; E Stefanski; M Wloch; P Vadas
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.